KL
Karl Lewis
Medical Oncology
Credentials: · ·
History
- 2002–2004
Medical Oncology
- 1999–2002
Internal Medicine
1995–1999
Research
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
New England Journal of Medicine · 2012 · 2,234 citations
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Journal of Clinical Oncology · 2015 · 2,112 citations
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
New England Journal of Medicine · 2012 · 1,763 citations
- RG
55 papers
28 papers
23 papers
20 papers
- RK
17 papers · 6 as a resident
16 papers · 1 as a fellow
15 papers
15 papers
